• Profile
Close

Trazodone use and risk of dementia: A population-based cohort study

PLoS Medicine Mar 07, 2019

Brauer R, et al. – Via analysis of UK population-based electronic health records, researchers evaluated the correlation between trazodone use and the risk of developing dementia in clinical practice. Between January 2000 and January 2017, patients from The Health Improvement Network (THIN) aged ≥ 50 years who received ≥ 2 consecutive prescriptions for an antidepressant were evaluated. Using a Cox regression model with 1:5 propensity score matching, the risk of dementia was compared among patients prescribed trazodone with patients who had similar baseline characteristics but were prescribed other antidepressants. Eligible patients prescribed trazodone (n=4,716; 59.2% female) were older and had a greater likelihood of developing cerebrovascular disease and using anxiolytic or antipsychotic drugs vs those prescribed other antidepressants (n=420,280; 59.7% female). No association was found between trazodone use and a reduced risk of dementia vs other antidepressants. According to findings, a reduced risk of dementia was not related to the clinical use of trazodone.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay